Latest filing published 05 Apr 2022 for Acutus Medical, Inc., €861.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Steven McQuillan: trading record in brief
This profile gathers the share dealings of Steven McQuillan in Acutus Medical, Inc., where the filings describe the role as chief executive. Between 1 April 2021 and 1 April 2022, the trades on record add up to 4 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 5 April 2022, reports a share grant of €861 in Acutus Medical, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Steven McQuillan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 733 shares@ US$1.30100.0% of flowCommon StockSEC:0000950103-22-006021:0
- 32,000 shares0Common StockSEC:0000950103-22-002002:0
- 305 shares@ €13.112845.1% of flowCommon StockSEC:0000950103-21-013064:0
3 of 3 declarations
